Diffusion Pharmaceuticals Inc expected to post a loss of $2.00 a share - Earnings Preview

CervoMed

06/05/2022 19:33

* Diffusion Pharmaceuticals Inc  DFFN.OQ   DFFN.O  is
expected
to show no change in quarterly revenue when it reports 
results on May 9 (estimated). 
    * ​Refinitiv's mean analyst estimate for Diffusion
Pharmaceuticals
Inc is for a loss of $2.00 per share. For the same quarter last
year, the company reported a loss of $3.00 per share.
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Diffusion
Pharmaceuticals Inc is $100​, above​ its last closing price
of $6.98. ​​​

This summary was machine generated May 6 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated